|
0
|
|
Beyond treatment intensification: The next questions after CAPITAL.
(linkinghub.elsevier.com)
|
Ogawa R
…
Mizusawa J
Cell Med
2026-09-11
|
#gastric cancer
#surgery
#chemotherapy
#clinical trial
|
|
0
|
|
The fear in the waiting room.
(linkinghub.elsevier.com)
|
Pereira F
…
Ambati J
Cell Med
2026-09-11
|
#inflammation
#clinical trial
#ophthalmology
#immunotherapy
|
|
0
|
|
Pancreatic ductal adenocarcinoma: Clinical trials to watch.
(linkinghub.elsevier.com)
|
Groot VP
…
Van Santvoort HC
Cell Med
2026-09-11
|
#cancer
#clinical trial
#precision-oncology
#immunotherapy
#chemotherapy
|
|
0
|
|
Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.
(linkinghub.elsevier.com)
|
Undurraga M
…
Ris F
EBioMedicine
2026-09-11
|
#clinical trial
#chemotherapy
#peritoneal-carcinomatosis
#toxicity
#drug delivery
|
|
0
|
|
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial.
(nature.com)
|
Nadeem O
…
Ghobrial IM
Nature Medicine
2026-09-11
|
#multiple myeloma
#immunotherapy
#bispecific antibody
#clinical trial
#minimal residual disease
|
|
0
|
|
Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.
(linkinghub.elsevier.com)
|
Doshi RH
…
Hyde TB
The Lancet
2026-09-11
|
#vaccination
#immunogenicity
#yellow fever
#clinical trial
#pediatrics
|